![Murray Stewart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Murray Stewart
Direktor/Vorstandsmitglied bei X4 PHARMACEUTICALS, INC.
Vermögen: 193 419 $ am 31.05.2024
Aktive Positionen von Murray Stewart
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
X4 PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.03.2019 | - |
Technik-/Wissenschafts-/F&E-Leiter | 29.11.2022 | 01.08.2023 | |
Vivli Center For Global Clinical Research Data | Direktor/Vorstandsmitglied | - | - |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Murray Stewart
Ehemalige bekannte Positionen von Murray Stewart
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VECTIVBIO HOLDING AG | Direktor/Vorstandsmitglied | 02.09.2021 | 26.06.2023 |
Independent Dir/Board Member | 02.09.2021 | 26.06.2023 | |
AMARIN CORPORATION PLC | Direktor/Vorstandsmitglied | 10.01.2023 | 06.03.2023 |
Independent Dir/Board Member | 10.01.2023 | 06.03.2023 | |
RHYTHM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.10.2018 | 10.09.2021 |
NOVELION THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.11.2017 | 17.10.2018 |
GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2014 | 01.11.2017 |
Corporate Officer/Principal | - | - |
Ausbildung von Murray Stewart
The University of Southampton | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 3 |
Schweiz | 3 |
Operativ
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
AMARIN CORPORATION PLC | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Novelion Therapeutics, Inc.
![]() Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Vivli Center For Global Clinical Research Data | |
VectivBio Holding AG
![]() VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Börse
- Insiders
- Murray Stewart
- Erfahrung